BrightGene Bio-Medical Technology Co. Ltd Financials

Market Capitalization CN¥23.72 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	170.00
Forward PE	95.08
Price to Sales TTM	CN¥19.91
Price to Book MRQ	CN¥9.69
Enterprise to Revenue	20.76
Enterprise to EBITDA	119.10

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	11.59%
Operating Margin	-2.70%
Return on Assets TTM	1.26%
Return on Equity TTM	2.94%

Income Statement

Revenue TTM	CN¥1,191,378,304
Revenue per Share TTM	CN¥2.83
Quarterly Revenue Growth	-26.80%
Gross Profit TTM	CN¥637,006,016
EBITDA	CN¥164,656,908
Net Income to Common TTM	CN¥138,056,800
Diluted EPS TTM	CN¥0.33
Quarterly Earnings Growth YoY	-79.80%

Balance Sheet

Total Cash MRQ	CN¥812,681,664
Total Cash per Share MRQ	CN¥1.88
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	85.40
Current Ratio MRQ	1.68
Book Value per Share MRQ	CN¥5.79

Cash Flow

Operating Cash Flow TTM	CN¥204,090,528
Levered Free Cash Flow TTM	CN¥-223,428,624

688166 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	422,466,646
Float Shares	288,471,699
Avg 10 Volume	8,361,730
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	39.27%
% Held by Institutions	12.00%

Stock Price Summary

Beta	0.16
Fifty Two Week Low	CN¥22.82
Fifty Two Week High	CN¥60.24
Fifty Two Week Change	35.06%
Day 50 MA	CN¥51.36
Day 200 MA	CN¥37.66

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.38
Forward Annual Dividend Yield	0.68%
Trailing Annual Dividend Rate	CN¥0.10
Trailing Annual Dividend Yield	0.17%
Payout Ratio	29.09%
Dividend Date
Ex Dividend Date	2025-06-23
Last Split Factor
Last Split Date